Novartis shareholders approve 100% spinout of Sandoz unit (NVS)
TBE/iStock Editorial via Getty Images Novartis (NYSE:NVS) shareholders have voted for a 100% spinout of the company's generic drug and biosimilars unit Sandoz, with shares of the new company to be listed on the SIX Swiss Exchange.…
